Inventor · disambiguated record
Donald E. Frail
Also filed as: FRAIL DONALD E · FRAIL DONALD EDWARD
4 granted patents·7 pending applications·42 citations·filing 1995–2021
74Inventor score
Top patents by PatentIndex Score
11 records- 0172US5854001AHepatitis C virus fusion proteinsABBOTT LAB·Filed 1996·Granted Dec 29, 1998·28 cites·3 claims
- 0270US11149262B2Botulinum toxin cell binding domain polypeptides and methods of use for skin rejuvenationALLERGAN INC·Filed 2018·Granted Oct 19, 2021·1 cites·4 claims
- 0366US7371207B2Estrogen receptor α regulated gene expression, related assays and therapeuticsWYETH CORP·Filed 2003·Granted May 13, 2008·1 cites·5 claims
- 0459US5667992AMammalian expression systems for HCV proteinsABBOTT LAB·Filed 1995·Granted Sep 16, 1997·12 cites·2 claims
- 0554US2021277377A1Botulinum toxin cell binding domain polypeptides and methods of use for treatments of fibrosis associated disordersALLERGAN INC·Filed 2021·Application pending·0 cites
- 0652US2009029382A1Characterization of a membrane estrogen receptorWYETH CORP·Filed 2008·Application pending·0 cites
- 0743US2004248925A1Use of 4-phenyl substituted tetrahydroisoquinolines in the treatment of pain, migraine and urinary incontinenceFRAIL DONALD E·Filed 2003·Application pending·0 cites
- 0839US2004248932A1Use of aryl- and heteroaryl-substituted tetrahydroisoquinolines in the treatment of chronic and neuropathic pain, migraine headaches, and urge, stress and mixed urinary incontinenceFiled 2003·Application pending·0 cites
- 0939US2004248933A1Use of 4-phenyl-substituted tetrahydroisoquinolines in the treatment of pain, migraine headaches and urinary incontinenceFiled 2003·Application pending·0 cites
- 1037US2006287226A9Characterization of a membrane estrogen receptorDEECHER DARLENE C·Filed 2002·Application pending·0 cites
- 1137US2008085244A1Methods for identifying and using amyloid-inhibitory compoundsWYETH CORP·Filed 2007·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Donald E. Frail files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →